Title | Drug Products not Withdrawn from Sale for Reasons of Safety or Effectiveness: NORFLEX (Orphenadrine Citrate) Injection, 30 Milligrams/Milliliter, and NORFLEX (Orphenadrine Citrate) Extended-Release Tablet, 100 Milligrams |
ToC Doc | NORFLEX (Orphenadrine Citrate) Injection, 30 Milligrams/Milliliter, and NORFLEX (Orphenadrine Citrate) Extended-Release Tablet, 100 Milligrams |
Docket Number | 2022-26663 |
Type | Notice |
Subject | Drug Products not Withdrawn from Sale for Reasons of Safety or Effectiveness: NORFLEX (Orphenadrine Citrate) Injection, 30 Milligrams/Milliliter, and NORFLEX (Orphenadrine Citrate) Extended-Release Tablet, 100 Milligrams |
Publication Date | 2022-12-08 |
Last Updated Date | 2022-12-07 08:15:09 -0500 |
Last Public Inspection | 2022-12-07 |
Filed At | 2022-12-07T08:45:00.000-05:00 |
2022-26663_PI.pdf (93923 bytes) | |
Download | TXT / HTML / JSON |
Number of Pages | 4 |
Filing Type | regular |
Agencies | Food and Drug Administration |
You can find the raw source document below...